Knust, H., Achermann, G., Ballard, T., Buettelmann, B., Gasser, R., Fischer, H., . . . Waldmeier, P. (2009). The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction. Bioorganic & medicinal chemistry letters, 19(20), 5940. https://doi.org/10.1016/j.bmcl.2009.08.053
Chicago Style (17th ed.) CitationKnust, Henner, et al. "The Discovery and Unique Pharmacological Profile of RO4938581 and RO4882224 as Potent and Selective GABAA Alpha5 Inverse Agonists for the Treatment of Cognitive Dysfunction." Bioorganic & Medicinal Chemistry Letters 19, no. 20 (2009): 5940. https://doi.org/10.1016/j.bmcl.2009.08.053.
MLA (9th ed.) CitationKnust, Henner, et al. "The Discovery and Unique Pharmacological Profile of RO4938581 and RO4882224 as Potent and Selective GABAA Alpha5 Inverse Agonists for the Treatment of Cognitive Dysfunction." Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 20, 2009, p. 5940, https://doi.org/10.1016/j.bmcl.2009.08.053.